CHDI Foundation

Evotec, CHDI Foundation extend collaboration in Huntington's

Tuesday, October 30, 2012 12:23 PM

CHDI Foundation, a privately-funded not-for-profit research organization dedicated to developing therapies for Huntington's disease, has extended its collaboration with Evotec, a drug discovery alliance and development partnership company based in Germany, until the end of 2015. The contract extension could be worth up to $41 million in research payments for Evotec.

More... »


Galenea, CHDI Foundation expand Huntington's disease collaboration

Friday, August 10, 2012 10:20 AM

Galenea, a Cambridge, Mass.-based company focused on synaptic transmission drug discovery, and CHDI Foundation, a not-for-profit, biomedical research organization focused on Huntington’s disease (HD), have extended and expanded their collaboration to further characterize the synaptic dysfunction apparent in HD utilizing Galenea’s proprietary platform.

More... »


CHDI Foundation selects Greenphire technology for global clinical payment

Friday, June 1, 2012 12:42 PM

CHDI Foundation, a non-profit biomedical research organization focused on Huntington’s disease (HD), will be implementing Philadelphia-based Greenphire’s two flagship payment technology platforms, eClinicalGPS and ClinCard System, to enhance its payment capability in the upcoming Enroll-HD global observational study.

More... »

Lundbeck, CHDI Foundation collaborate on Huntington’s disease

Tuesday, May 22, 2012 10:23 AM

Lundbeck, a pharmaceutical company based in Deerfield, Ill. and CHDI Foundation, a not-for-profit biomedical research organization, have formed a research collaboration to investigate a targeted therapy for Huntington’s disease.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2013 CenterWatch.